Bayer may merge animal health unit with Elanco; report

AbbVie ducks bolt-on trend and agrees Allergan mega-merger

UnitedHealth buys PatientsLikeMe after Trump intervention

The US health services giant UnitedHealth Group has bought PatientsLikeMe, which had been forced to find a buyer by the Trump administration because of its links with China.

As Lyrica patent expiry looms, Pfizer buys Array for $11.4bn

Pfizer has a made a $48 per share play for Array Biopharma, which values the cancer specialist at $11.4 billion.

Roche delays Spark merger again amid reviews in US and UK

Roche’s $4.3 billion takeover of US gene therapy specialist Spark Therapeutics has been pushed back again because regulators are concerned over its impact on competition.

Nine for 2019: Challenges impacting pharma

As we move close to 2019’s halfway point, it’s time to reflect on the issues that are shaping the pharmaceutical industry for this year and beyond.